- +708.7% price growth over the last year
- High gross margin of 89.5%
- Highly efficient cash conversion (100% FCF/OCF ratio)
Green day on Wednesday for Verrica Pharmaceuticals Inc stock after gaining 4.78%
(Updated on Jul 22, 2026)
The Verrica Pharmaceuticals Inc stock price gained 4.78% on the last trading day (Wednesday, 22nd Jul 2026), rising from $5.44 to $5.70. During the last trading day the stock fluctuated 6.10% from a day low at $5.41 to a day high of $5.74. The price has fallen in 7 of the last 10 days and is down by -13.9% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 25 thousand more shares were traded than the day before. In total, 36 thousand shares were bought and sold for approximately $207.93 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.42 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.14% during the next 3 months and, with a 90% probability hold a price between $4.65 and $6.35 at the end of this 3-month period.
VRCA Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, July 21, 2026, and so far it has risen 4.78%. Further rise is indicated until a new top pivot has been found. Verrica Pharmaceuticals Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Verrica Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.96. On a fall, the stock will find some support from the short-term average at $5.62. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Verrica Pharmaceuticals Inc stock
Verrica Pharmaceuticals Inc finds support from accumulated volume at $5.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.330 between high and low, or 6.10%. For the last week, the stock has had daily average volatility of 7.27%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (VRCA) For The Upcoming Trading Day Of Thursday 23rd
For the upcoming trading day on Thursday, 23rd we expect Verrica Pharmaceuticals Inc to open at $5.62, and during the day (based on 14 day Average True Range), to move between $5.48 and $5.92, which gives a possible trading interval of +/-$0.447 (+/-8.17%) up or down from last closing price. If Verrica Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.17% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $5.65 (0.88%) than the resistance at $6.83 (19.74%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Verrica Pharmaceuticals Inc stock A Buy?
Verrica Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-2.090
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 23, 2026 - $5.62 ( 1.46%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VRCA Performance
Trading levels for VRCA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 5.95 | 4.33% |
| R2 | 5.82 | 2.12% |
| R1 | 5.74 | 0.750% |
| Price | 5.70 | |
| S1 | 5.49 | -3.67% |
| S2 | 5.41 | -5.04% |
| S3 | 5.29 | -7.25% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.98 | 22.46% |
| R2 | 6.84 | 20.00% |
| R1 | 6.83 | 19.74% |
| Price | 5.70 | |
| S1 | 5.65 | -0.88% |
| S2 | 5.64 | -1.05% |
| S3 | 5.59 | -1.93% |
FAQ
Click here for our free guide on how to buy Verrica Pharmaceuticals Inc Stock.
Buy VRCA